変種に適応したCOVID-19ブースターワクチン
Florian Krammer1,2,3, Ali H Ellebedy4,5
1Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
まとめ
現行のワクチンは,新興のSARS-CoV-2変種に効果的に闘うためにアップデートする必要があります. 未来の大流行の準備と制御には ワクチンの調整が不可欠です
科学分野:
- ウイルス学
- 免疫学
- ワクチン学
背景:
- 深刻な急性呼吸器症候群コロナウイルス2型 (SARS-CoV-2) の出現は,既存のワクチンの有効性にとって大きな課題となっています.
- ウイルスの進化の継続的なモニタリングは公衆衛生にとって不可欠です.
研究 の 目的:
- SARS-CoV-2に対する適応的なワクチン戦略の必要性を強調する.
- 将来のウイルス株に合わせたワクチンの開発の重要性を強調する.
主な方法:
- 現在のSARS-CoV-2変種特性のレビュー.
- 既知の変種に対するワクチンの免疫反応データの分析
主要な成果:
- 既存のワクチンは,SARS-CoV-2の特定の変種に対する有効性が低下しています.
- ウイルスの変異は中和抗体のレベルに影響を与えます.
結論:
- ワクチン製剤は,進化するSARS-CoV-2の状況に対応するために更新されなければならない.
- COVID-19に対する持続的な保護のために,積極的なワクチンの適応が必要である.
関連する概念動画
Vaccinations
44.6K
Overview
44.6K
Special Features of Adaptive Immunity
841
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
841
Cancer Vaccines
384
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
384
Cross-reactivity
31.2K
Overview
31.2K
Antigens Involved in Adaptive Immunity
512
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
512
Cells of the Adaptive Immune Response
1.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.0K


